Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Factor Xa Inhibitors Versus Vitamin K Antagonists for Preventing Cerebral or Systemic Embolism in Patients With Atrial Fibrillation." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434848/2/images/tooltip-triangle.png. Accessed 02 May 2024.
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434848/2/images/tooltip-triangle.png. Accessed May 2, 2024.
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434848/2/images/tooltip-triangle.png
Factor Xa Inhibitors Versus Vitamin K Antagonists for Preventing Cerebral or Systemic Embolism in Patients With Atrial Fibrillation [Internet]. In: Cochrane Abstracts. [cited 2024 May 02]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434848/2/images/tooltip-triangle.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
ID - 434848
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434848/2/images/tooltip-triangle.png
DB - Evidence Central
DP - Unbound Medicine
ER -